Standardized SEC financial data for GLAUKOS Corp — income statement, balance sheet, cash flow and 40+ ratios, available as a clean JSON API. CIK 0001192448 · NYSE · Surgical & Medical Instruments & Apparatus.
Ratios for fiscal year 2025, standardized from SEC filings.
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $225.0M | $294.0M | $282.9M | $314.7M | $383.5M | $507.4M |
| Cost of revenue | $91.7M | $66.6M | $69.0M | $75.6M | $94.0M | $111.8M |
| Gross profit | $133.2M | $227.4M | $213.9M | $239.1M |
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $413.9M | $423.5M | $126.6M | $99.3M | $174.4M | $94.6M |
| Inventory | $15.8M | $23.0M | $37.8M | $42.0M | $57.7M | $63.6M |
| Total current assets | $469.4M | $486.1M | $443.9M | $395.5M |
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$23.0M | $24.7M | -$33.1M | -$57.8M | -$61.3M | -$14.8M |
| Capital expenditures | $6.9M | $47.8M | $30.3M | $20.2M | $6.3M | $7.7M |
| Free cash flow | -$29.9M | -$23.1M | -$63.3M | -$78.0M |
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/GKOS/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/GKOS/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"| $289.5M |
| $282.8M |
| R&D expense | $85.4M | $101.0M | $123.3M | $138.8M | $136.4M | $150.6M |
| SG&A expense | $171.4M | $179.3M | $192.9M | $224.1M | $261.2M | $331.7M |
| Operating income | -$123.6M | -$32.9M | -$82.3M | -$128.7M | -$122.4M | -$199.6M |
| EBITDA | -$94.2M | -$3.2M | -$50.7M | -$95.0M | -$86.7M | -$161.5M |
| Interest expense | $14.1M | $13.4M | $13.7M | $13.6M | $4.5M | $4.2M |
| Pretax income | -$132.3M | -$49.3M | -$98.4M | -$133.7M | -$145.6M | -$193.0M |
| Income tax | $12.0M | $326K | $766K | $934K | $771K | $5.4M |
| Net income | -$120.3M | -$49.6M | -$99.2M | -$134.7M | -$146.4M | -$187.7M |
| EPS (diluted) | $-2.70 | $-1.07 | $-2.09 | $-2.78 | $-2.77 | $-3.28 |
Standardized from GLAUKOS Corp's SEC filings — per-share figures split-adjusted. Full history via the API.
| $449.8M |
| $475.0M |
| Property, plant & equipment | $24.0M | $69.0M | $94.4M | $103.2M | $97.9M | $113.3M |
| Goodwill | $66.1M | $66.1M | $66.1M | $66.1M | $66.1M | $66.7M |
| Total assets | $1.01B | $1.05B | $1.00B | $940.4M | $974.8M | $893.5M |
| Total current liabilities | $49.7M | $63.4M | $72.4M | $74.0M | $75.1M | $101.3M |
| Total liabilities | $338.1M | $462.5M | $472.4M | $478.6M | $207.8M | $237.3M |
| Retained earnings | -$310.1M | -$365.2M | -$464.4M | -$599.1M | -$745.4M | -$933.1M |
| Total equity | $667.4M | $587.2M | $530.0M | $461.8M | $766.9M | $656.2M |
| -$67.6M |
| -$22.5M |
| Investing cash flow | -$205.1M | -$58.2M | $44.8M | $14.1M | $47.8M | -$77.6M |
| Financing cash flow | $262.5M | $39.3M | $6.3M | $15.0M | $91.5M | $11.9M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 | $0 |